Miami, Florida (PRWEB) October 07, 2013
Global Stem Cells Group, Inc. announced plans to attend 21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine (a4m) at the Venetian/Palazzo Hotel in Las Vegas, Dec. 15, 2013. The prestigious conference, hosted by the American Academy of Anti-aging Medicine, will be attended by physicians and medical practitioners from around the world who will discuss practice management stem cell technology, certification, personalized lifestyle medicine, aesthetic medicine, pellet therapy, brain health, case studies and. Workshops on personalized lifestyle medicine and aesthetic medicine will also be held.
Joseph Purita, M.D., a lead trainer for Stem Cell Training, Inc. and a pioneer in the use of stem cell therapies in orthopedics, will be a featured speaker at the conference. Purita joins an illustrious group of speakers including: Author Judith Reichman, M.D., women’s health care expert and specialist in gynecology, infertility and menopause; Travis Stork, M.D., ER physician and host of the Emmy Award-winning talk show, “The Doctors;” and Actress and Author Suzanne Somers, a dedicated health advocate and proponent of alternative and integrative medicine.
Global Stem Cells Group plans to promote its new postgraduate program, “Studies in Cellular Therapy and Tissue Engineering”, in partnership with Maimonides University, as well its newly formed alliance with EmCyte Corp. to promote in-office regenerative medicine solutions. Fort Myers, Florida-based EmCyte is a leading provider of biotechnology solutions in the United States, develops biological products for platelet rich plasma and bone marrow concentrate grafting procedures.
For more information on the World Congress on Anti-Aging, Regenerative and Aesthetic Medicine, visit the a4m website, email bnovas(at)regenestem(dot)com or call 849.943.2988.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
The Global Stem Cell Foundation was formed as a nonprofit charitable organization that aims to fund research on the expanding need for stem cell solutions for patients, and identify best practices between physicians engaged in stem cell treatments in the U.S. and around the world.
To learn more about Global Stem Cells Group, Inc., and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.